Systemic therapy of metastatic breast cancer: a plea for confirmation of subtypes by genomic assays
J Cancer Res Clin Oncol
.
2022 Jun;148(6):1275-1276.
doi: 10.1007/s00432-022-03989-0.
Epub 2022 Apr 12.
Author
Diana Lüftner
1
Affiliation
1
Department of Hematology, Oncology and Tumor Immunology, Charité Campus Benjamin Franklin, University Medicine Berlin, Hindenburgdamm 30, 12200, Berlin, Germany. diana.lueftner@t-online.de.
PMID:
35415795
PMCID:
PMC9114085
DOI:
10.1007/s00432-022-03989-0
No abstract available
Publication types
Editorial
MeSH terms
Breast Neoplasms* / drug therapy
Breast Neoplasms* / genetics
Breast Neoplasms* / pathology
Female
Genomics
Humans